Molecular Diagnostics Market in Cancer and Infectious Disease Testing

Oct 22, 2015, 08:30 ET from ReportsnReports

PUNE, India, October 22, 2015 /PRNewswire/ -- announces addition of molecular diagnostics market research reports for 2015 with role of molecular diagnostics in cancer testing as well as infectious disease testing industries with a discussion on companies active in the sector.

Complete report on molecular diagnostics market in cancer testing spread across 231 pages, profiling 34 companies and supported with 93 tables and 31 figures is now available at .

Molecular diagnostics market covers a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy.

This molecular diagnostics market report focused on cancer testing describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

Companies profiled in this research on molecular diagnostics market in cancer testing include Abbott Molecular Diagnostics, Accugenomics, Inc., Agendia, Ambry Genetics, Biodesix, bioMérieux, bioTheranostics (AviaraDx), Cancer Genetics, Inc., Clarient, Inc. (GE Healthcare), Counsyl, Flatiron Health, Epigenomics, Exact Sciences Corporation, Exiqon, Genomic Health, Inc., Genoptix, Inc. (Novartis), Genmark Diagnostics, Genomictree, HTG Molecular Diagnostics, Invitae, LabCorp, Myriad Genetics, Inc., Nanostring, Neogenomics, NSTG, Nuvera Biosciences, Orion Genomics, Pathway Genomics, Personal Genome Diagnostics, Quest Diagnostics, Rosetta Genomics Ltd., Signal Genetics, Source MDx and Wilex, Inc. Order a copy of Molecular Diagnostics in Cancer Testing 2015 market research report at .

The second market research titled Molecular Diagnostics in Infectious Disease Testing describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation.

Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acid-mediated molecular diagnostics testing. The purpose of this report is to describe the emerging field of molecular diagnostics market in infectious disease testing. The infectious disease space is the most dominant and profitable sector of molecular diagnostics. Topics covered in this study include: 1) the existing and emerging technologies in the field, 2) the U.S. and global market size for molecular diagnostic products and 3) the profiles of companies that are focusing on the molecular diagnostic sector. The research examines drivers and restraints for sales growth, market share and technical trends. In addition, an in-depth analysis of the competitive situation of prominent market venders is provided with five-year sales forecasts.

Companies like Abbott Laboratories, AdvanDx, Affymetrix, Arcxis Biotechnologies, Asuragen, Inc., AutoGenomics, Inc., Becton, Dickinson and Company, bioMérieux, Biocartis, BioHelix Corporation (now part of Quidel), bioTheranostics, Cepheid, EraGen Biosciences, GenMark Diagnostics, Inc., Genomix Biotech, Gen-Probe, Inc. (now known as Hologic Gen-Probe), Genomica S.A.U., Great Basin Corporation, Illumina, Inc., Life Technologies (Thermo Fisher Scientific), Luminex Corp., Mobidiag, Myconostica, Myriad Genetics, Inc., Nanosphere, NorDiag ASA (The DiaSorin Group), Qiagen N.V., Quidel, Roche Diagnostics (Roche Ltd.), SACACE, Seegene, Siemens AG, SIRS-Lab, TrimGen, TrovaGene, Veredus Laboratories and Veridex, LLC (Janssen Diagnostics, LLC) are profiled in this 441 pages research available at .

Explore more reports on the healthcare market at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441

Connect With Us on:  



Twitter: https: //

G+ / Google Plus:


RSS/Feeds:  http: //

SOURCE ReportsnReports